Logo image of IPA

IMMUNOPRECISE ANTIBODIES LTD (IPA) Stock Price, Quote, News and Overview

NASDAQ:IPA - Nasdaq - CA45257F2008 - Common Stock - Currency: USD

0.466  +0.03 (+5.67%)

After market: 0.4502 -0.02 (-3.39%)

IPA Quote, Performance and Key Statistics

IMMUNOPRECISE ANTIBODIES LTD

NASDAQ:IPA (2/4/2025, 8:00:02 PM)

After market: 0.4502 -0.02 (-3.39%)

0.466

+0.03 (+5.67%)

Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryLife Sciences Tools & Services
Statistics
52 Week High2.43
52 Week Low0.32
Market Cap13.43M
Shares28.83M
Float25.10M
Yearly Dividend0
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO01-30 1987-01-30


IPA short term performance overview.The bars show the price performance of IPA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30

IPA long term performance overview.The bars show the price performance of IPA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of IPA is 0.466 USD. In the past month the price decreased by -10.37%. In the past year, price decreased by -78.43%.

IMMUNOPRECISE ANTIBODIES LTD / IPA Daily stock chart

IPA Latest News, Press Releases and Analysis

News Image
13 days ago - Chartmill

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.

News Image
13 days ago - Chartmill

Which stocks are most active on Wednesday?

Curious about the most active stocks on Wednesday? Find out which stocks are dominating the market action!

News Image
14 days ago - Chartmill

Let's take a look at the stocks that are in motion in today's session.

Top movers in Wednesday's session

News Image
14 days ago - Chartmill

Gapping stocks in Wednesday's session

Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session.

News Image
13 days ago - Benzinga

What's Going On With ImmunoPrecise Antibodies Stock Wednesday?

Immunoprecise shares closed higher on Wednesday after the company announced it developed a new class of GLP-1 therapies.

IPA Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 26.56 222.07B
DHR DANAHER CORP 28.71 155.30B
A AGILENT TECHNOLOGIES INC 27.8 41.93B
IQV IQVIA HOLDINGS INC 18.42 36.31B
MTD METTLER-TOLEDO INTERNATIONAL 35.12 28.27B
WAT WATERS CORP 36.03 24.37B
WST WEST PHARMACEUTICAL SERVICES 48.97 23.97B
ILMN ILLUMINA INC 71.79 19.70B
ICLR ICON PLC 13.78 15.96B
RVTY REVVITY INC 25.13 14.99B
AVTR AVANTOR INC 22.46 14.98B
TECH BIO-TECHNE CORP 40.53 11.53B

About IPA

Company Profile

IPA logo image ImmunoPrecise Antibodies Ltd. is a therapeutic antibody discovery company, which engages in the provision of human therapeutic antibody discovery and development services. The company is headquartered in Victoria, British Columbia. The firm owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. The company has several subsidiaries in North America and Europe including entities, such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The firm utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.

Company Info

IMMUNOPRECISE ANTIBODIES LTD

3204-4464 Markham St.

Victoria BRITISH COLUMBIA CA

Employees: 87

Company Website: https://www.ipatherapeutics.com/

Investor Relations: https://www.immunoprecise.com/investors/

Phone: 16048060626

IPA FAQ

What is the stock price of IPA?

The current stock price of IPA is 0.466 USD.


What is the symbol for IMMUNOPRECISE ANTIBODIES LTD stock?

The exchange symbol of IMMUNOPRECISE ANTIBODIES LTD is IPA and it is listed on the Nasdaq exchange.


On which exchange is IPA stock listed?

IPA stock is listed on the Nasdaq exchange.


Is IPA a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for IPA, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of IPA.


Does IPA stock pay dividends?

IPA does not pay a dividend.


What is the Price/Earnings (PE) ratio of IPA?

IPA does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.31).


What is the Short Interest ratio of IPA stock?

The outstanding short interest for IPA is 0.14% of its float.


IPA Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to IPA. When comparing the yearly performance of all stocks, IPA is a bad performer in the overall market: 92.54% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

IPA Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to IPA. IPA has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IPA Financial Highlights

Over the last trailing twelve months IPA reported a non-GAAP Earnings per Share(EPS) of -0.31. The EPS decreased by 28.13% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -45.92%
ROE -84.27%
Debt/Equity 0.45
Chartmill High Growth Momentum
EPS Q2Q%10%
Sales Q2Q%-0.41%
EPS 1Y (TTM)28.13%
Revenue 1Y (TTM)6.36%

IPA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 80% to IPA. The Buy consensus is the average rating of analysts ratings from 6 analysts.

For the next year, analysts expect an EPS growth of 14.37% and a revenue growth 0.58% for IPA


Ownership
Inst Owners6.07%
Ins Owners1.34%
Short Float %0.14%
Short Ratio0
Analysts
Analysts80
Price Target5.1 (994.42%)
EPS Next Y14.37%
Revenue Next Year0.58%